Literature DB >> 18299886

Adrenaline potentiates insulin-stimulated PKB activation in the rat fast-twitch epitrochlearis muscle without affecting IRS-1-associated PI 3-kinase activity.

Jørgen Jensen1, Line M Grønning-Wang, Einar Jebens, Jonathan P Whitehead, Robert Zorec, Peter R Shepherd.   

Abstract

We have previously shown in the rat slow-twitch soleus muscle that adrenaline greatly potentiates insulin-stimulated protein kinase B (PKB) phosphorylation without having an effect alone. However, insulin signalling capacity through the PKB pathway is higher in soleus than in fast-twitch muscles, whereas adrenaline activates phosphorylase more strongly in epitrochlearis. Therefore, the aim of the present study was to investigate the interaction between adrenaline and insulin signalling in the fast-twitch epitrochlearis muscle. Insulin increased insulin receptor substrate-1 (IRS-1)-associated phosphoinositide (PI) 3-kinase activity threefold, and adrenaline did not influence basal or insulin-stimulated PI 3-kinase activity. Insulin but not adrenaline increased PKB activity and phosphorylation of Ser(473) and Thr(308). It is interesting to note that adrenaline potentiated insulin-stimulated PKB activity and PKB Ser(473) and Thr(308) phosphorylation. These effects were mimicked by dibutyryl-cyclic adenosine monophosphate (db-cAMP). Adrenaline and db-cAMP increased glycogen synthase kinase (GSK)-3beta Ser(9) phosphorylation independently of PKB activation and enhanced insulin-stimulated GSK-3beta Ser(9) phosphorylation. Although adrenaline increased GSK-3 phosphorylation (inhibiting activity), phosphorylation of its target sites on glycogen synthase was increased, and adrenaline blocked insulin-stimulated glycogen synthase dephosphorylation of Ser(641) and Ser(645,649,653,657), glycogen synthase activation and glycogen synthesis. Insulin-stimulated glucose transport was not influenced by adrenaline despite the increased PKB activation. In conclusion, as in the slow-twitch soleus muscle, adrenaline potentiates insulin-stimulated PKB activation in the fast-twitch glycolytic epitrochlearis muscle without increasing IRS-1-associated PI 3-kinase activity. Furthermore, adrenaline induces phosphorylation of a pool of GSK-3 that is not involved in the regulation of glycogen metabolism. These results indicate that the combination of adrenaline and insulin may activate novel signalling molecules rather than just summing up their effects on linear pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299886     DOI: 10.1007/s00424-008-0471-z

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  47 in total

1.  The origins of protein phosphorylation.

Authors:  Philip Cohen
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

Review 2.  Cellular and molecular diversities of mammalian skeletal muscle fibers.

Authors:  D Pette; R S Staron
Journal:  Rev Physiol Biochem Pharmacol       Date:  1990       Impact factor: 5.545

3.  Adrenaline-mediated glycogenolysis in different skeletal muscle fibre types in the anaesthetized rat.

Authors:  J Jensen; H A Dahl; P K Opstad
Journal:  Acta Physiol Scand       Date:  1989-06

4.  GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3.

Authors:  Jørgen Jensen; Erlend O Brennesvik; Yu-Chiang Lai; Peter R Shepherd
Journal:  Cell Signal       Date:  2006-08-24       Impact factor: 4.315

5.  Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase.

Authors:  J Franch; R Aslesen; J Jensen
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

6.  Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression.

Authors:  Mark E Cleasby; Tracie A Reinten; Gregory J Cooney; David E James; Edward W Kraegen
Journal:  Mol Endocrinol       Date:  2006-10-04

7.  Effects of insulin and epinephrine on Na+-K+ and glucose transport in soleus muscle.

Authors:  T Clausen; J A Flatman
Journal:  Am J Physiol       Date:  1987-04

8.  Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms.

Authors:  S K Moule; G I Welsh; N J Edgell; E J Foulstone; C G Proud; R M Denton
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

9.  Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase.

Authors:  N Filippa; C L Sable; C Filloux; B Hemmings; E Van Obberghen
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

10.  Improved insulin-stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylation.

Authors:  J Jensen; J Ruzzin; E Jebens; E O Brennesvik; S Knardahl
Journal:  Acta Physiol Scand       Date:  2005-06
View more
  3 in total

1.  Beta-adrenoceptor stimulation potentiates insulin-stimulated PKB phosphorylation in rat cardiomyocytes via cAMP and PKA.

Authors:  Jorid T Stuenaes; Astrid Bolling; Ada Ingvaldsen; Camilla Rommundstad; Emina Sudar; Fang-Chin Lin; Yu-Chiang Lai; Jørgen Jensen
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Chronic β2 -adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men.

Authors:  Morten Hostrup; Johan Onslev; Glenn A Jacobson; Richard Wilson; Jens Bangsbo
Journal:  J Physiol       Date:  2017-11-12       Impact factor: 5.182

3.  The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise.

Authors:  Jørgen Jensen; Per Inge Rustad; Anders Jensen Kolnes; Yu-Chiang Lai
Journal:  Front Physiol       Date:  2011-12-30       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.